Predicted protein targets (top 7)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | MAPT | P10636 | 1/20 | 0.69 |
| ▸ | KMT2A | Q03164 | 7/20 | 0.67 |
| ▸ | MEN1 | O00255 | 6/20 | 0.67 |
| ▸ | ALDH1A1 | P00352 | 3/20 | 0.60 |
| ▸ | L3MBTL1 | Q9Y468 | 2/20 | 0.57 |
| ▸ | GAA | P10253 | 1/20 | 0.53 |
| ▸ | P2RX7 | Q99572 | 1/20 | 0.52 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL9818694 | 0.83 | CNR1 (0.62) | MAPTKMT2AMEN1ALDH1A1L3MBTL1 | |
| SCHEMBL9818712 | 0.82 | ALDH1A1 (0.69) | MAPTKMT2AMEN1ALDH1A1L3MBTL1 | |
| SCHEMBL9818610 | 0.77 | TP53 (0.79) | MAPTKMT2AMEN1L3MBTL1 | |
| SCHEMBL9818742 | 0.75 | TP53 (0.62) | MAPTKMT2AMEN1ALDH1A1L3MBTL1 | |
| SCHEMBL10073037 | 0.75 | MEN1 (0.84) | KMT2AMEN1ALDH1A1L3MBTL1GAA | |
| SCHEMBL9818726 | 0.75 | TP53 (0.62) | MAPTKMT2AMEN1ALDH1A1L3MBTL1 | |
| SCHEMBL3904049 | 0.75 | MEN1 (0.97) | KMT2AMEN1ALDH1A1L3MBTL1 | |
| SCHEMBL9818724 | 0.75 | CNR1 (0.63) | MAPTKMT2AMEN1ALDH1A1L3MBTL1 | |
| Hydrochloric Acid SCHEMBL2891114 | 0.74 | MEN1 (0.53) | MAPTKMT2AMEN1ALDH1A1L3MBTL1 | |
| SCHEMBL9818668 | 0.74 | CNR1 (0.70) | KMT2AMEN1ALDH1A1L3MBTL1 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-5015644-A | Antihyperlipidemic and antiatherosclerotic urea and carbamate compounds | WARNER-LAMBERT COMPANY (US) | 1991-05-14 | — | — | US | disclosed |